These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 15220248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance.
    Marathe CS, Pham H, Marathe JA, Trahair LG, Huynh L, Wu T, Phillips LK, Rayner CK, Nauck MA, Horowitz M, Jones KL.
    Acta Diabetol; 2020 May; 57(5):583-587. PubMed ID: 31848710
    [Abstract] [Full Text] [Related]

  • 8. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [Abstract] [Full Text] [Related]

  • 9. Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.
    Wice BM, Reeds DN, Tran HD, Crimmins DL, Patterson BW, Dunai J, Wallendorf MJ, Ladenson JH, Villareal DT, Polonsky KS.
    Diabetes; 2012 Jul; 61(7):1793-800. PubMed ID: 22522617
    [Abstract] [Full Text] [Related]

  • 10. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome.
    Calanna S, Urbano F, Piro S, Zagami RM, Di Pino A, Spadaro L, Purrello F, Rabuazzo AM.
    Eur J Endocrinol; 2012 May; 166(5):917-22. PubMed ID: 22391044
    [Abstract] [Full Text] [Related]

  • 11. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA.
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [Abstract] [Full Text] [Related]

  • 12. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [Abstract] [Full Text] [Related]

  • 13. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.
    Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vänttinen M, Stancáková A, Jansson PA, Pellmé F, Holst JJ, Kuulasmaa T, Hribal ML, Sesti G, Stefan N, Fritsche A, Häring H, Pedersen O, Smith U, EUGENE2 Consortium.
    Diabetologia; 2008 Mar; 51(3):502-11. PubMed ID: 18080106
    [Abstract] [Full Text] [Related]

  • 14. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
    Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, Barbara L.
    J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
    [Abstract] [Full Text] [Related]

  • 15. Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.
    Hyltén-Cavallius L, Iepsen EW, Wewer Albrechtsen NJ, Svendstrup M, Lubberding AF, Hartmann B, Jespersen T, Linneberg A, Christiansen M, Vestergaard H, Pedersen O, Holst JJ, Kanters JK, Hansen T, Torekov SS.
    Circulation; 2017 May 02; 135(18):1705-1719. PubMed ID: 28235848
    [Abstract] [Full Text] [Related]

  • 16. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA, Siemsglüss J, Orskov C, Holst JJ.
    Z Gastroenterol; 1996 Mar 02; 34(3):159-66. PubMed ID: 8650968
    [Abstract] [Full Text] [Related]

  • 17. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Jones IR, Owens DR, Luzio S, Williams S, Hayes TM.
    Diabetologia; 1989 Sep 02; 32(9):668-77. PubMed ID: 2676668
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older Subjects.
    Pham H, Marathe CS, Phillips LK, Trahair LG, Hatzinikolas S, Huynh L, Wu T, Nauck MA, Rayner CK, Horowitz M, Jones KL.
    J Clin Endocrinol Metab; 2019 Dec 01; 104(12):6201-6206. PubMed ID: 31393567
    [Abstract] [Full Text] [Related]

  • 19. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
    Ebert R, Creutzfeldt W.
    Acta Diabetol Lat; 1989 Dec 01; 26(1):1-15. PubMed ID: 2665406
    [Abstract] [Full Text] [Related]

  • 20. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.
    Diabetes Care; 1998 Jan 01; 21(1):76-9. PubMed ID: 9538973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.